Edition:
United Kingdom

BioLine RX Ltd (BLRX.OQ)

BLRX.OQ on NASDAQ Stock Exchange Capital Market

0.98USD
21 Sep 2018
Change (% chg)

$-0.10 (-9.72%)
Prev Close
$1.08
Open
$1.08
Day's High
$1.09
Day's Low
$0.95
Volume
314,290
Avg. Vol
62,029
52-wk High
$1.34
52-wk Low
$0.78

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 4 0.03 0.10 0.00 0.00
Quarter Ending Dec-18 4 0.04 0.15 0.00 0.00
Year Ending Dec-18 4 0.06 0.25 0.00 2.55
Year Ending Dec-19 4 16.20 63.60 0.00 26.77
Earnings (per share)
Quarter Ending Sep-18 4 -0.05 -0.05 -0.06 -0.06
Quarter Ending Dec-18 4 -0.06 -0.05 -0.06 -0.06
Year Ending Dec-18 4 -0.22 -0.21 -0.23 -0.02
Year Ending Dec-19 4 -0.14 0.14 -0.26 -0.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.68 32.76
P/E High - Last 5 Yrs. -- 300.70 45.44
P/E Low - Last 5 Yrs. -- 92.08 24.26
Beta -- 0.93 0.89
Price to Sales (TTM) -- 114.98 5.74
Price to Book (MRQ) -- 15.51 5.00
Price to Tangible Book (MRQ) -- 14.62 6.57
Price to Cash Flow (TTM) -- 72.88 23.29
% Owned Institutions -- 14.70 2.21

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.51
Dividend Yield - 5 Year Avg -- 0.26 1.52
Dividend 5 Year Growth Rate -- 1.72 5.22
Payout Ratio(TTM) -- 16.50 43.78

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 411.53 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 80.36 5.63
Sales - 5 Yr. Growth Rate -- 32.26 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 29.14 20.61
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 39.84 10.66
Capital Spending - 5 Yr. Growth Rate -- 40.42 15.34

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.91 2.22
Current Ratio (MRQ) -- 5.46 3.03
LT Debt to Equity (MRQ) -- 35.27 12.51
Total Debt to Equity (MRQ) -- 37.09 16.85
Interest Coverage (TTM) -- -102.34 32.65

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 39.18 54.37
Gross Margin - 5 Yr. Avg. -- 50.58 52.17
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -600.62 10.68
Operating Margin (TTM) -- -759.72 4.32
Operating Margin - 5 Yr. Avg. -- -621.65 6.11
Pre-Tax Margin (TTM) -- -733.57 5.18
Pre-Tax Margin - 5 Yr. Avg. -- -627.35 6.51
Net Profit Margin (TTM) -- -734.94 1.48
Net Profit Margin - 5 Yr. Avg. -- -630.39 2.78
Effective Tax Rate (TTM) -- 23.33 23.11
Effective Tax Rate - 5 Yr. Avg. -- 18.66 23.97

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 23,228,954 860,374,110
Net Income/Employee (TTM) -- 3,144,136 101,207,069
Receivable Turnover (TTM) -- 20.89 5.87
Inventory Turnover (TTM) -- 2.46 3.41
Asset Turnover (TTM) -- 0.41 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -0.15 11.13
Return on Assets - 5 Yr. Avg. -- 3.51 12.40
Return on Investment (TTM) -- 1.78 14.61
Return on Investment - 5 Yr. Avg. -- 2.56 16.13
Return on Equity (TTM) -- 3.27 16.33
Return on Equity - 5 Yr. Avg. -- 3.43 17.39
Note: Units in Millions of US Dollars

Performance for BioLine RX Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.